ACIP: 2023 Adult Immunization Schedule Updates
Several changes have been made to the adult immunization schedule 2023.
Diagnosis & Disease Information
M-M-R II, Varivax, ProQuad Vaccines Approved for Intramuscular Administration
M-M-R II, Varivax, and ProQuad are supplied in single-dose vials as lyophilized vaccine for SC or IM injection after reconstitution.
Bivalent RSV Maternal Vaccine Candidate Gets FDA’s Priority Review
The BLA is supported by data from a phase 3 trial which included approximately 7400 pregnant individuals.
Shingles: Raising Awareness and Promoting Vaccination
Despite the availability of a highly effective shingles vaccine and almost universal risk among those born before 1980, Americans are not getting vaccinated.
Lack of Efficacy Ends Trial Evaluating Janssen’s HIV Vaccine Candidate
The decision to discontinue the study was made based on an analysis from an independent data and safety monitoring board.
Adacel Approved for Use During Pregnancy to Prevent Pertussis in Infants
The approval was based on a re-analysis of data from on observational study of Tdap vaccine effectiveness in the US.
Pfizer, BioNTech Submit EUA Request for Bivalent COVID-19 Vaccine in Younger Children
The bivalent vaccine contains the original strain of the SARS-CoV-2 virus and a strain from the BA.4 and BA.5 lineages of the Omicron variant.
CDC: Priorix, M-M-R II Fully Interchangeable for MMR Vaccination
Immune responses after Priorix administration were noninferior to those observed with M-M-R II.
New Formulation of Rotarix Removes the Need for Reconstitution
The new liquid formulation of Rotarix does not require reconstitution or dilution before use.
Maternal RSV Vaccine Candidate Provides Protection for Infants in Phase 3 Trial
The RSVpreF vaccine candidate consists of 2 prefusion F proteins selected to optimize protection against RSV A and B.
- Loading...
Loading...
Loading... 
Loading...